Correlation Between RenovoRx and Oruka Therapeutics,
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Oruka Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Oruka Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Oruka Therapeutics,, you can compare the effects of market volatilities on RenovoRx and Oruka Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Oruka Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Oruka Therapeutics,.
Diversification Opportunities for RenovoRx and Oruka Therapeutics,
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between RenovoRx and Oruka is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Oruka Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oruka Therapeutics, and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Oruka Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oruka Therapeutics, has no effect on the direction of RenovoRx i.e., RenovoRx and Oruka Therapeutics, go up and down completely randomly.
Pair Corralation between RenovoRx and Oruka Therapeutics,
Given the investment horizon of 90 days RenovoRx is expected to generate 0.78 times more return on investment than Oruka Therapeutics,. However, RenovoRx is 1.28 times less risky than Oruka Therapeutics,. It trades about 0.42 of its potential returns per unit of risk. Oruka Therapeutics, is currently generating about -0.41 per unit of risk. If you would invest 98.00 in RenovoRx on August 27, 2024 and sell it today you would earn a total of 31.00 from holding RenovoRx or generate 31.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
RenovoRx vs. Oruka Therapeutics,
Performance |
| Timeline |
| RenovoRx |
| Oruka Therapeutics, |
RenovoRx and Oruka Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and Oruka Therapeutics,
The main advantage of trading using opposite RenovoRx and Oruka Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Oruka Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oruka Therapeutics, will offset losses from the drop in Oruka Therapeutics,'s long position.| RenovoRx vs. Eliem Therapeutics | RenovoRx vs. HCW Biologics | RenovoRx vs. Scpharmaceuticals | RenovoRx vs. Milestone Pharmaceuticals |
| Oruka Therapeutics, vs. Eliem Therapeutics | Oruka Therapeutics, vs. HCW Biologics | Oruka Therapeutics, vs. Scpharmaceuticals | Oruka Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |